Literature DB >> 21858634

[Hypertension short message service].

Dieter Magometschnigg1, Gustav Rothmayer.   

Abstract

Hypertension Short Message Service is a new tool for disease management aimed at improving the success of the doctor's daily routine in hypertension treatment both in terms of the quality of hypertension assessment and concerning the efficacy of treatment. At present there is a wide and disappointing difference between the results of treatment in routine work [1] and in clinical trials [2, 3] even when the same cohort of patients is treated by the same therapists. The efficacy rate in daily routine is about 20-35% as compared to 70-85% during trials. Assuming this gap is due to differences in disease management we integrated short message service and Internet applications into a new hypertension management tool (Blutdrucksms). According to our registry data "Blutdrucksms" is very successful: More than 80% of our hypertensive patients were treated to target. In June 2008, we implemented the SMS-Blood Pressure Protocol, and in October 2010, we analyzed the data of all "Blutdrucksms" users available in our registry. By then a total of 568 patients - 44% female and 56% male - had sent their self-recorded blood pressure readings as short messages to the SMS-Center; 75% of these patients had had at least one organ damage (left ventricular hypertrophy, increase in intima media thickening or carotid plaque). Mean casual blood pressure, recorded before enrolment into the SMS-program, was 152/83. It had improved to 136/80 mmHg by October 2010. The mean of the self-recorded blood pressures of the last month of participation was 128/76 mmHg and a heart rate of 69 beats per minute; 85% of all hypertensive patients had their pressures at treatment goal. Thus, we assume that "Blutdrucksms" is an excellent tool to improve the efficacy of antihypertensive disease management in routine work. We assume that the success is due to the enhanced communication between patient and doctor via SMS. As we are aware of the weakness of registry analysis we try to set up a controlled prospective study to compare "Blutdrucksms" users to non-users.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858634     DOI: 10.1007/s10354-011-0010-y

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  7 in total

1.  Cardiovascular protection and blood pressure reduction: a meta-analysis.

Authors:  J A Staessen; J G Wang; L Thijs
Journal:  Lancet       Date:  2001-10-20       Impact factor: 79.321

2.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

3.  Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.

Authors:  Thomas A Burke; Miriam C Sturkenboom; Shou-en Lu; Charles E Wentworth; Yong Lin; George G Rhoads
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

4.  Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.

Authors:  Sverre E Kjeldsen; Kenneth A Jamerson; George L Bakris; Bertram Pitt; Björn Dahlöf; Eric J Velazquez; Jitendra Gupte; Linda Staikos; Tsushung A Hua; Victor Shi; Allen Hester; Jaakko Tuomilehto; Jan Ostergren; Hans Ibsen; Michael Weber
Journal:  Blood Press       Date:  2008       Impact factor: 2.835

Review 5.  Worldwide prevalence of hypertension: a systematic review.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul K Whelton; Jiang He
Journal:  J Hypertens       Date:  2004-01       Impact factor: 4.844

6.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

7.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

  7 in total
  1 in total

1.  Hypertensive patients' readiness to use of mobile phones and other information technological modes for improving their compliance to doctors' advice in Karachi.

Authors:  Mirza Izhar Hussain; Baqir S Naqvi; Iqbal Ahmed; Nasir Ali
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.